Johnspeed
Lv31
210 积分
2024-02-22 加入
-
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
2小时前
已完结
-
Role of interferon regulatory factor 5 (IRF5) in tumor progression: Prognostic and therapeutic potential
8天前
已完结
-
Novel agents in development for the treatment of resistant Gram-negative infections
28天前
已完结
-
Rewiring Cancer Drivers to Activate Apoptosis
1个月前
已完结
-
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
-
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
1个月前
已完结
-
Targeting guanine nucleotide exchange factors for novel cancer drug discovery
2个月前
已关闭
-
Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase
2个月前
已完结
-
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?
2个月前
已完结
-
Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments
2个月前
已完结